HomeAbout us Management Board of Directors Scientific Advisory Board Therapeutic Areas Pipeline Investors Careers News Contact Dr. Bruno Oesch, Chief Executive Officer   Bruno Oesch initiated Neurotune as a spin-off from Prionics AG in 2005. Since the start of the company he served as the President of the Board of directors and was strongly involved in the development of Neurotune strategy. Previously, Bruno also co-founded Prionics AG as a spin-off from the University of Zurich in early 1997 and acts as Co-CEO, Head of R&D and Chairman of the Board of Prionics. He graduated from the ETH Zurich with a Master's degree in Natural Sciences. For his PhD in prion diseases, he joined Prof. Charles Weissmann at the University of Zurich. Later, he worked at the University of California in San Francisco in Prof. Stanley Prusiner's Lab. Subsequently he established his own research group at the Brain Research Institute of the University of Zurich, out of which Prionics was started. [BACK] © Copyright by Neurotune Switzerland